Indian court to rule on generic drug industry DailyFinance Earlier this year, an Indian manufacturer was allowed to produce a far cheaper version of the kidney and liver cancer treatment sorefinib, manufactured by Bayer Corp. Bayer was selling the drug for about $5,600 a month. Natco, the Indian company, said ... |
